Extrapyramidal signs following zimelidine overdose

Area of Science:

• Pharmacology
• Neuroscience
• Clinical Toxicology

Background:

• Zimelidine is an antidepressant medication.
• Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depression.
• Antidepressant overdose cases provide valuable insights into drug toxicity and mechanisms.

Observation:

• A 35-year-old female patient ingested a significant overdose of zimelidine (5g).
• Plasma levels confirmed zimelidine and norzimelidine concentrations.
• Physical examinations and electrocardiograms (EKGs) over 12 hours showed no altered consciousness or significant QT prolongation.

Findings:

• The patient developed a distinct extrapyramidal syndrome.
• This syndrome is characterized by movement abnormalities.
• The observed symptoms align with animal studies indicating potential dopamine-receptor blockade by zimelidine.

Implications:

• Zimelidine's potential to block dopamine receptors warrants further investigation.
• This finding could influence the clinical use and understanding of zimelidine's side effect profile.
• Extrapyramidal symptoms in overdose cases highlight the importance of monitoring neurological function.